Compare DexCom, Inc. (DXCM) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs SkyWest Inc — how do they compare? DexCom, Inc. trades at $77.82 (market cap $28.06B), while SkyWest Inc trades at $100.15 (market cap $3.95B). The key difference: DexCom, Inc. is far larger — about 7.1× SkyWest Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | SKYW | |
|---|---|---|
Market Cap | $28.06B | $3.95B |
Sector | Health | Technology |
52-Week High | $89.53 | $123.72 |
52-Week Low | $54.84 | $78.40 |
Enterprise Value | $27.03B | $5.79B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
SkyWest (SKYW) trades at $100.50, up 3.41% with strong technical momentum and bullish analyst sentiment. The stock shows solid fundamentals with a P/E of 9.54, net margin of 10.42%, and recent earnings beats. Recent management changes and consistent profitability support the positive outlook despite fuel cost pressures affecting the airline industry.
The stock presents upside potential with a consensus price target of $109.33 (8.8% upside) and no sell ratings. Key risks include volatile fuel costs and industry margin pressures, but strong cash flow generation and attractive valuation provide a compelling risk-reward profile for investors seeking exposure to regional airlines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
